McDonald's was taken to task by speakers associated with an …
Creating an embryo just from an egg and a skin cell seems like …
The makers of a diabetes and weight loss drug suspected in the …
Advertisement
US panel sees risk in long-used osteoporosis drug
Little evidence drug works, say health experts
Updated: Tuesday, 05 Mar 2013, 4:18 PM EST
Published : Tuesday, 05 Mar 2013, 4:18 PM EST
WASHINGTON (AP) - A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.
The Food and Drug Administration panel voted 12-9 that the risks of the inhalable osteoporosis drug outweigh its benefits for postmenopausal women with brittle bones.
The drug, known chemically as calcitonin salmon, has been prescribed for osteoporosis in postmenopausal women since the 1980s. Currently the drug is sold in nasal spray form by Novartis and Upsher-Smith.
But the health authorities around the world have been reviewing the drug's safety after two recent studies showed a slightly higher rate of cancer among patients taking calcitonin pills.
Comments WLFI.com is migrating to a more stable commenting system called DISQUS. This system is used by CNN, TIME, FOX News, numerous blogging sites and has over 75 Million registered users. Unfortunately we can't migrate our current user accounts to this new system.
To sign up for a DISQUS account, click the DISQUS button just below and to the right and then click Login.
DISQUS lets you login with several different options, including Facebook, Google, Twitter, Yahoo or OpenID. We expect it to allow more conversation and better moderation. If you have any questions, please feel free to comment below.
Email This
Print This
View Story on a Single PageAdvertisement
Advertisement